Clinical Trials in Maryland

Showing 19901-19920 of 23,284 trials

A Study to Investigate the Neuroprotective Effect of PROCRIT (Epoetin Alfa) Versus Placebo in Cancer Patients Who Develop Chemotherapy-induced Peripheral Neuropathy

NCT00267007

The purpose of this study is to evaluate the neuroprotective effect of PROCRIT (epoetin alfa, a glycoprotein that stimulates red blood cell production) versus placebo in patients with cancer who develop chemotherapy-induced peripheral neuropathy due to combination Taxane and Platinum-Based treatment.

Peripheral Neuropathy, Chemotherapy-induced

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.32 participantsStarted Jun 2006

Mobile, Alabama, United States • Little Rock, Arkansas, United States • Alhambra, California, United States +25 more locations

COMPLETEDPhase 417 miles

An Efficacy and Safety Study of One Dosage of Paliperidone Extended Release (ER) in Treating Patients With Schizophrenia

NCT00524043

The purpose of this study is to assess the efficacy and safety of 1.5 mg/day dose of paliperidone Extended Release (ER) as compared with placebo when used to treat patients with schizophrenia.

Schizophrenia

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.201 participantsStarted Sep 2007

Cerritos, California, United States • Torrance, California, United States • Washington D.C., District of Columbia, United States +17 more locations

A Study to Investigate the Neuroprotective Effect of PROCRIT (Epoetin Alfa) Versus Placebo in Cancer Patients Who Develop Chemotherapy-induced Peripheral Neuropathy

An Efficacy and Safety Study of One Dosage of Paliperidone Extended Release (ER) in Treating Patients With Schizophrenia

Find Trials by Condition in Maryland

A Trial of Degarelix in Patients With Prostate Cancer

Safety and Efficacy of AST-120 Compared to Lactulose in Patients With Hepatic Encephalopathy

Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Patients With Stage III Non-small Cell Lung Cancer

Fresh-Frozen Plasma Infusions to Reduce Risk of Bleeding Related to Invasive Procedures

Vorinostat and Trastuzumab in Treating Patients With Metastatic or Locally Recurrent Breast Cancer

An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men

Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma

Carboplatin, Paclitaxel, and Bevacizumab With or Without Erlotinib Hydrochloride in Treating Non-Smokers With Advanced Non-Small Cell Lung Cancer

Pazopanib in Treating Patients With Metastatic Urothelial Cancer

VX-950-C211 - A Dosing Regimen Study (Twice Daily Versus Every 8 Hours) of Telaprevir in Treatment-naïve Participants With Genotype 1 Chronic Hepatitis C Virus Infection

Growth and Tolerance of Infants Fed Infant Formulas

Evaluate the Safe and Effective Use of the Avonex® Single-Use Autoinjector in Multiple Sclerosis Subjects

Selumetinib in Treating Patients With Locally Advanced or Metastatic Liver Cancer

Dose Finding Study In Subjects With Crow's Feet

Computed Tomography Dose Reduction Using Sequential or Fast Pitch Sprial Technique

Safety of Urate Elevation in Parkinson's Disease

Inhaled Iloprost for the Treatment of Persistent Pulmonary Hypertension in the Term and Near Term Infants.

Evaluation of Monthly Darbepoetin Alfa Dosing for Correction of Anemia in Non-dialysis Chronic Kidney Disease